AM Hanby
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 6
- MicroRNA in disease regulation 2
-
- Breast Lesions and Carcinomas 6
- Genetic factors in colorectal cancer 3
- Co-authors
- Nicholas A. WrightMike OwenAdrian HaydayL DiandaA. SebestenyRichard PoulsomValerie SpeirsIR Hart
- Journals
- Cancer Research (5 papers)Breast Cancer Research (3 papers)British Journal of Cancer (2 papers)Journal of Clinical Pathology (2 papers)Blood (2 papers)
- Partner nations
- United KingdomNetherlandsSingapore
In The Last Decade
AM Hanby
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 295
- Oncology 325
- Pathology and Forensic Medicine 173
- Immunology 202
- Gastroenterology 44
Countries citing papers authored by AM Hanby
This map shows the geographic impact of AM Hanby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AM Hanby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AM Hanby more than expected).
Fields of papers citing papers by AM Hanby
This network shows the impact of papers produced by AM Hanby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AM Hanby. The network helps show where AM Hanby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside AM Hanby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of perioperative lapatinib and trastuzumab, alone and in combination, in early HER2+breast cancer - the UK EPHOS-B trial (CRUK/08/002) | 2016 | 4 |
| 2 | 2014 | 84 | |
| 3 | 2014 | 27 | |
| 4 | 2013 | 11 | |
| 5 | 2008 | 60 | |
| 6 | 2007 | 9 | |
| 7 | 2006 | 36 | |
| 8 | 2006 | 1 | |
| 9 | 2005 | 6 | |
| 10 | 2004 | 138 | |
| 11 | 2004 | 37 | |
| 12 | 2004 | 30 | |
| 13 | Molecular analysis of phyllodes tumours reveals distinct changes in the epithelial and stromal components | 2000 | 3 |
| 14 | T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. | 1997 | 279 |
| 15 | Allele loss, replication errorsandlossofexpression ofE-cadherin incolorectal cancers | 1997 | 1 |
| 16 | Transgenic mice which overexpress the human trefoil peptide, pS2, have an increased resistance to intestinal damage | 1996 | 3 |
| 17 | 1995 | 108 | |
| 18 | 1993 | 28 | |
| 19 | 1993 | 28 | |
| 20 | 1987 | 9 |
About AM Hanby
AM Hanby is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Molecular Biology and Genetics, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (6 papers), Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (3 papers), Genetic factors in colorectal cancer (3 papers), Estrogen and related hormone effects (3 papers), T-cell and Retrovirus Studies (2 papers), MicroRNA in disease regulation (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Cancer Research (295 citations), Oncology (325 citations), Pathology and Forensic Medicine (173 citations), Immunology (202 citations) and Gastroenterology (44 citations). AM Hanby has collaborated with scholars based in United Kingdom, Netherlands and Singapore. Frequent co-authors include Nicholas A. Wright, Mike Owen, Adrian Hayday, L Dianda, A. Sebesteny, Richard Poulsom, Valerie Speirs, IR Hart, J M A Northover and Sina Dorudi. Their work appears in journals such as Cancer Research, Breast Cancer Research, British Journal of Cancer, Journal of Clinical Pathology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.